Investigación Clínica en Infección VIH, Infección Endovascular y Bacteriemias

Lineas de Investigación

01. Infección por el VIH.

02. Otras infecciones de transmisión sexual.

03. Infecciones endovascular y bacteriemias

04. Infecciones osteoarticulares.



Estudios Clínicos

201636. Estudio Fase III aleatorizado, multicéntrico, de grupos paralelos, de no inferioridad, para evaluar la eficacia, seguridad y tolerabilidad del cambio de una terapia antirretroviral basada en INI, ITINN o IP a dolutegravir más rilpivirina en pacientes adul

LABORATORIOS VIIV HEALTHCARE S.L.
Fase: III ENSAYO CLINICO COMERCIAL

SYMTRI. SYMTRI Study: Ensayo clínico abierto, aleatorizado y multicéntrico para comparar la eficacia, seguridad y tolerabilidad de una pauta de tratamiento TAF/FTC/DRV/cobi vs. ABC/3TC/DTG en pacientes infectados por el VIH-1 naïve de tratamiento antirretroviral.

RED DE INVESTIGACIÓN EN SIDA
Fase: IV ENSAYO CLINICO INDEPENDIENTE

GS-US-311-1717.

Estudio de fase 3b, aleatorizado, doble ciego, con cambio de tratamiento para evaluar F/TAF, en pacientes con infección por VIH-1 y supresión virológica que reciben tratamientos que contienen ABC/3TC

GILEAD SCIENCES, INC
Fase: IIIb ENSAYO CLINICO COMERCIAL

GS-US-380-1878.

Estudio fase III, aleatorizado y abierto para evaluar la seguridad y eficacia del cambio de un régimen formado por atazanavir o darunavir reforzados más emtricitabina/tenofovir o abacavir/lamivudina a GS 9883/emtricitabina/tenofovir alafenamida en adultos

GILEAD SCIENCES, INC
Fase: III ENSAYO CLINICO COMERCIAL

GS-US-380-1490.

Estudio de fase 3, aleatorizado y doble ciego para evaluar la seguridad y la eficacia de GS-9883/emtricitabina/tenofovir alefenamida en comparación con dolutegravir + emtricitabina/tenofovir alefenamida en adultos infectados por el VIH-1 sin tratamiento a

GILEAD SCIENCES, INC
Fase: III ENSAYO CLINICO COMERCIAL

204862. Estudio de fase III, aleatorizado, multicéntrico, con grupos paralelos y de ausencia de inferioridad para evaluar la eficacia, la seguridad y la tolerabilidad del cambio a dolutegravir más lamivudina en adultos infectados por el VIH 1 con supresión viroló

VIIV HEALTHCARE UK LIMITED
Fase: III ENSAYO CLINICO COMERCIAL

Publicaciones científicas

  • Todo
  • D1
  • Q1
  • Q2
  • Otro
  1. Real, LM, Fernández-Fuertes, M, Sáez, ME, Rivero-Juárez, A, Frías, M, Téllez, F et al.. A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study). Liver Int. 2019;39 (10):1918-1926. doi: 10.1111/liv.14177. PubMed PMID:31206233 .
Search PubMed
  1. Pérez-Molina, JA, Martínez, E, Blasco, AJ, Arribas, JR, Domingo, P, Iribarren, JA et al.. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2019;37 (3):151-159. doi: 10.1016/j.eimc.2018.04.010. PubMed PMID:29884455 .
Search PubMed
  1. Hidalgo-Tenorio, C, Cortés, LL, Gutiérrez, A, Santos, J, Omar, M, Gálvez, C et al.. DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients. Medicine (Baltimore). 2019;98 (32):e16813. doi: 10.1097/MD.0000000000016813. PubMed PMID:31393412 PubMed Central PMC6708975.
Search PubMed
  1. Jarrin, I, Suarez-Garcia, I, Moreno, C, Tasias, M, Del Romero, J, Palacios, R et al.. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015. Antivir Ther. 2019;24 (3):167-175. doi: 10.3851/IMP3297. PubMed PMID:30747107 .
Search PubMed
  1. Macías, J, Téllez, F, Rivero-Juárez, A, Palacios, R, Morano, LE, Merino, D et al.. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients. J Viral Hepat. 2019;26 (1):48-54. doi: 10.1111/jvh.13003. PubMed PMID:30199593 .
Search PubMed
  1. Pasquau, J, de Jesus, SE, Arazo, P, Crusells, MJ, Ríos, MJ, Lozano, F et al.. Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study). BMC Infect Dis. 2019;19 (1):207. doi: 10.1186/s12879-019-3817-6. PubMed PMID:30819101 PubMed Central PMC6396540.
Search PubMed
  1. Frías, M, Rivero-Juárez, A, Téllez, F, Palacios, R, Jiménez-Arranz, Á, Pineda, JA et al.. Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR. Sci Rep. 2019;9 (1):12507. doi: 10.1038/s41598-019-48966-9. PubMed PMID:31467339 PubMed Central PMC6715682.
Search PubMed
  1. Panel of Experts from the Metabolic Disorders and Comorbilities Study Group (GEAM), Aids Study Group (GeSIDA), National Aids Plan (PNS). Electronic address: rpolor@msssi.es. Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. Enferm Infecc Microbiol Clin. 2019;37 (1):50-55. doi: 10.1016/j.eimc.2017.06.007. PubMed PMID:28823613 .
Search PubMed
  1. AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients. Enferm Infecc Microbiol Clin. ;37 (7):467-475. doi: 10.1016/j.eimc.2018.03.011. PubMed PMID:29793873 .
Search PubMed
  1. AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan:. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018). Enferm Infecc Microbiol Clin. 2019;37 (3):195-202. doi: 10.1016/j.eimc.2018.02.010. PubMed PMID:29759422 .
Search PubMed
  1. Jiménez Villodres, M, García Gutiérrez, G, García Frías, P, Rioja Villodres, J, Martín Velázquez, M, Sánchez Chaparro, MÁ et al.. Fractional excretion of phosphorus and vascular calcification in stage 3 chronic kidney disease. J Investig Med. 2019;67 (3):674-680. doi: 10.1136/jim-2018-000852. PubMed PMID:30429202 .
Search PubMed
  1. Corma-Gómez, A, Macías, J, Merino Muñoz, D, Téllez, F, Granados, R, Morano, LE et al.. Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks. J Infect. 2019;79 (1):30-35. doi: 10.1016/j.jinf.2019.05.005. PubMed PMID:31100364 .
Search PubMed
  1. Corma-Gómez, A, Morano, L, Téllez, F, Rivero-Juárez, A, Real, LM, Alados, JC et al.. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals. AIDS. 2019;33 (7):1167-1174. doi: 10.1097/QAD.0000000000002186. PubMed PMID:30845068 .
Search PubMed
  1. Resino, S, Navarrete-Muñoz, MA, Blanco, J, Pacheco, YM, Castro, I, Berenguer, J et al.. IL7RA rs6897932 Polymorphism is Associated with Better CD4+ T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy. Biomolecules. 2019;9 (6):. doi: 10.3390/biom9060233. PubMed PMID:31208153 PubMed Central PMC6627042.
Search PubMed
  1. Gutiérrez-Saborido, D, Gutiérrez-Valencia, A, González Domenech, CM, López Ruz, MÁ, Raffo Márquez, M, Omar, M et al.. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy. Ann Hematol. 2019;98 (8):1953-1959. doi: 10.1007/s00277-019-03700-3. PubMed PMID:31025161 .
Search PubMed
  1. Ivanova-Georgieva, R, Ruiz-Morales, J, García-Cabrera, E, García-López, MV, Gálvez-Acebal, J, Plata-Ciezar, A et al.. Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious. Eur J Clin Microbiol Infect Dis. 2019;38 (2):265-275. doi: 10.1007/s10096-018-3423-3. PubMed PMID:30430377 .
Search PubMed
  1. Merchante, N, Figueruela, B, Rodríguez-Fernández, M, Rodríguez-Arrondo, F, Revollo, B, Ibarra, S et al.. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients. AIDS. 2019;33 (2):269-278. doi: 10.1097/QAD.0000000000002065. PubMed PMID:30325782 .
Search PubMed
  1. Machuca, J, López-Cerero, L, Fernández-Cuenca, F, Mora-Navas, L, Mediavilla-Gradolph, C, López-Rodríguez, I et al.. OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015. Antimicrob Agents Chemother. 2019;63 (1):. doi: 10.1128/AAC.01396-18. PubMed PMID:30323046 PubMed Central PMC6325174.
Search PubMed
  1. Rivero-Juarez, A, Tellez, F, Castaño-Carracedo, M, Merino, D, Espinosa, N, Santos, J et al.. Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients. HIV Med. 2019;20 (6):359-367. doi: 10.1111/hiv.12715. PubMed PMID:31006980 .
Search PubMed
  1. Domingo, P, Suarez-Lozano, I, Gutierrez, F, Estrada, V, Knobel, H, Palacios, R et al.. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study. Nefrologia. ;39 (5):497-505. doi: 10.1016/j.nefro.2019.01.009. PubMed PMID:31027896 .
Search PubMed
  1. Pérez, AB, Chueca, N, Macías, J, Pineda, JA, Salmerón, J, Rivero-Juárez, A et al.. Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort. PLoS One. 2019;14 (8):e0221231. doi: 10.1371/journal.pone.0221231. PubMed PMID:31469856 PubMed Central PMC6716636.
Search PubMed
  1. Knobel, H, Domingo, P, Suarez-Lozano, I, Gutierrez, F, Estrada, V, Palacios, R et al.. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain. Enferm Infecc Microbiol Clin. ;37 (6):373-379. doi: 10.1016/j.eimc.2018.09.015. PubMed PMID:30389268 .
Search PubMed
  1. Saludes, V, Antuori, A, Reinhardt, B, Viciana, I, Clavijo, E, Schreiber, L et al.. Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay. Sci Rep. 2019;9 (1):3678. doi: 10.1038/s41598-019-40099-3. PubMed PMID:30842623 PubMed Central PMC6403303.
Search PubMed
  1. Macías, J, Morano, LE, Téllez, F, Granados, R, Rivero-Juárez, A, Palacios, R et al.. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71 (1):45-51. doi: 10.1016/j.jhep.2019.02.018. PubMed PMID:30853642 .
Search PubMed
  1. Armiñanzas, C, Fariñas-Alvarez, C, Zarauza, J, Muñoz, P, González Ramallo, V, Martínez Sellés, M et al.. Role of age and comorbidities in mortality of patients with infective endocarditis. Eur J Intern Med. 2019;64 :63-71. doi: 10.1016/j.ejim.2019.03.006. PubMed PMID:30904433 .
Search PubMed
  1. Macías, J, Granados, R, Téllez, F, Merino, D, Pérez, M, Morano, LE et al.. Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection. J Viral Hepat. 2019;26 (1):16-24. doi: 10.1111/jvh.12990. PubMed PMID:30141222 .
Search PubMed
  1. Alvarez, M, Casas, P, de Salazar, A, Chueca, N, Guerrero-Beltran, C, Rodríguez, C et al.. Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice. J Antimicrob Chemother. 2019;74 (6):1693-1700. doi: 10.1093/jac/dkz067. PubMed PMID:30838386 .
Search PubMed
  1. de la Cruz Cosme, C, Dawid Milner, MS, Ojeda Burgos, G, Gallardo Tur, A, Márquez Martínez, M, Segura, T et al.. Validation of a basic neurosonology laboratory for detecting cervical carotid artery stenosis. Neurologia. ;34 (6):367-375. doi: 10.1016/j.nrl.2017.01.015. PubMed PMID:28347575 .
Search PubMed
  1. Pérez, AB, Chueca, N, Macías, J, Pineda, JA, Salmerón, J, Rivero-Juárez, A et al.. Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort. PLoS One. 2019;14 (8):e0221231. doi: 10.1371/journal.pone.0221231. PubMed PMID:31469856 PubMed Central PMC6716636.
Search PubMed
  1. Knobel, H, Domingo, P, Suarez-Lozano, I, Gutierrez, F, Estrada, V, Palacios, R et al.. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain. Enferm Infecc Microbiol Clin. ;37 (6):373-379. doi: 10.1016/j.eimc.2018.09.015. PubMed PMID:30389268 .
Search PubMed
  1. Saludes, V, Antuori, A, Reinhardt, B, Viciana, I, Clavijo, E, Schreiber, L et al.. Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay. Sci Rep. 2019;9 (1):3678. doi: 10.1038/s41598-019-40099-3. PubMed PMID:30842623 PubMed Central PMC6403303.
Search PubMed
  1. Macías, J, Morano, LE, Téllez, F, Granados, R, Rivero-Juárez, A, Palacios, R et al.. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71 (1):45-51. doi: 10.1016/j.jhep.2019.02.018. PubMed PMID:30853642 .
Search PubMed
  1. Armiñanzas, C, Fariñas-Alvarez, C, Zarauza, J, Muñoz, P, González Ramallo, V, Martínez Sellés, M et al.. Role of age and comorbidities in mortality of patients with infective endocarditis. Eur J Intern Med. 2019;64 :63-71. doi: 10.1016/j.ejim.2019.03.006. PubMed PMID:30904433 .
Search PubMed
  1. Macías, J, Granados, R, Téllez, F, Merino, D, Pérez, M, Morano, LE et al.. Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection. J Viral Hepat. 2019;26 (1):16-24. doi: 10.1111/jvh.12990. PubMed PMID:30141222 .
Search PubMed
  1. Alvarez, M, Casas, P, de Salazar, A, Chueca, N, Guerrero-Beltran, C, Rodríguez, C et al.. Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice. J Antimicrob Chemother. 2019;74 (6):1693-1700. doi: 10.1093/jac/dkz067. PubMed PMID:30838386 .
Search PubMed
  1. de la Cruz Cosme, C, Dawid Milner, MS, Ojeda Burgos, G, Gallardo Tur, A, Márquez Martínez, M, Segura, T et al.. Validation of a basic neurosonology laboratory for detecting cervical carotid artery stenosis. Neurologia. ;34 (6):367-375. doi: 10.1016/j.nrl.2017.01.015. PubMed PMID:28347575 .
Search PubMed
  1. Benito, JM, Ortiz, MC, León, A, Sarabia, LA, Ligos, JM, Montoya, M et al.. Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers. BMC Med. 2018;16 (1):30. doi: 10.1186/s12916-018-1026-6. PubMed PMID:29490663 PubMed Central PMC5830067.
Search PubMed
  1. AIDS Study Group (GESIDA), National Aids Plan,, STI Study group of the SEIMC (GEITS), Spanish Group for the Investigation of Sexual Transmission Diseases of the Spanish Academy of Dermatology and Venerology, Spanish Society for Pediatric Infectious (SEIP). Consensus document on the diagnosis and treatment of sexually transmitted diseases in adults, children and adolescents. Enferm Infecc Microbiol Clin. 2018;36 (9):576-585. doi: 10.1016/j.eimc.2017.06.004. PubMed PMID:28736100 .
Search PubMed
  1. Pérez-Parra, S, Álvarez, M, Fernandez-Caballero, JA, Pérez, AB, Santos, J, Bisbal, O et al.. Continued propagation of the CRF19_cpx variant among HIV-positive MSM patients in Spain. J Antimicrob Chemother. 2018;73 (4):1031-1038. doi: 10.1093/jac/dkx474. PubMed PMID:29325134 .
Search PubMed
  1. Rivero, A, Pérez-Molina, JA, Blasco, AJ, Arribas, JR, Asensi, V, Crespo, M et al.. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2018;36 (5):268-276. doi: 10.1016/j.eimc.2017.04.002. PubMed PMID:28532596 .
Search PubMed
  1. González-Domenech, CM, Viciana, I, Delaye, L, Mayorga, ML, Palacios, R, de la Torre, J et al.. Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain. PLoS One. 2018;13 (1):e0190544. doi: 10.1371/journal.pone.0190544. PubMed PMID:29309418 PubMed Central PMC5757947.
Search PubMed
  1. AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017). Enferm Infecc Microbiol Clin. ;36 (7):435-445. doi: 10.1016/j.eimc.2017.04.001. PubMed PMID:28579016 .
Search PubMed
  1. Ramos-Martínez, A, Muñoz Serrano, A, de Alarcón González, A, Muñoz, P, Fernández-Cruz, A, Valerio, M et al.. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis. J Infect Chemother. 2018;24 (7):555-562. doi: 10.1016/j.jiac.2018.03.003. PubMed PMID:29628387 .
Search PubMed
  1. Berenguer, J, Jarrín, I, Pérez-Latorre, L, Hontañón, V, Vivancos, MJ, Navarro, J et al.. Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant. Open Forum Infect Dis. 2018;5 (1):ofx258. doi: 10.1093/ofid/ofx258. PubMed PMID:29354658 PubMed Central PMC5767960.
Search PubMed
  1. Fernández-Hidalgo, N, Ribera, A, Larrosa, MN, Viedma, E, Origüen, J, de Alarcón, A et al.. Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect. 2018;24 (9):985-991. doi: 10.1016/j.cmi.2017.12.002. PubMed PMID:29269091 .
Search PubMed
  1. Ocampo, A, Domingo, P, Fernández, P, Diz, J, Barberá, JR, Sepúlveda, MA et al.. Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study. J Antimicrob Chemother. 2018;73 (8):2171-2176. doi: 10.1093/jac/dky175. PubMed PMID:29788066 .
Search PubMed
  1. Pineda, JA, Rivero-Juárez, A, de Los Santos, I, Collado, A, Merino, D, Morano-Amado, LE et al.. Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice. HIV Clin Trials. 2018;19 (1):23-30. doi: 10.1080/15284336.2018.1436637. PubMed PMID:29447085 .
Search PubMed
  1. Benito, JM, Hillung, J, Restrepo, C, Cuevas, JM, León, A, Ruiz-Mateos, E et al.. Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients. Int J Med Sci. 2018;15 (2):95-100. doi: 10.7150/ijms.22317. PubMed PMID:29333092 PubMed Central PMC5765721.
Search PubMed
  1. Palacios, R, Mayorga, M, González-Domenech, CM, Hidalgo-Tenorio, C, Gálvez, C, Muñoz-Medina, L et al.. Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study. J Int Assoc Provid AIDS Care. ;17 :2325958218760847. doi: 10.1177/2325958218760847. PubMed PMID:29529910 PubMed Central PMC6748491.
Search PubMed
  1. Merchante, N, Rivero-Juárez, A, Téllez, F, Merino, D, Ríos-Villegas, MJ, Villalobos, M et al.. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis. J Antimicrob Chemother. 2018;73 (9):2435-2443. doi: 10.1093/jac/dky234. PubMed PMID:29982683 .
Search PubMed
  1. Gómez Ayerbe, C, Santos González, J, Palacios Muñoz, R. Symtuza (DRV/c/FTC/TAF) in the management of treatment-naive HIV-patients. Enferm Infecc Microbiol Clin. 2018;36 Suppl 2 :17-21. doi: 10.1016/S0213-005X(18)30393-8. PubMed PMID:30545467 .
Search PubMed
  1. Jiménez-Garrido, C, Gómez-Palomo, JM, Rodríguez-Delourme, I, Durán-Garrido, FJ, Nuño-Álvarez, E, Montañez-Heredia, E et al.. The Kidney, Liver, Index surgery and C reactive protein score is a predictor of treatment response in acute prosthetic joint infection. Int Orthop. 2018;42 (1):33-38. doi: 10.1007/s00264-017-3670-4. PubMed PMID:29075808 .
Search PubMed
  1. Goenaga Sánchez, MÁ, Kortajarena Urkola, X, Bouza Santiago, E, Muñoz García, P, Verde Moreno, E, Fariñas Álvarez, MC et al.. Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics. Med Clin (Barc). 2017;149 (8):331-338. doi: 10.1016/j.medcli.2017.03.009. PubMed PMID:28431897 .
Search PubMed
  1. Rivero, A, Pérez-Molina, JA, Blasco, AJ, Arribas, JR, Crespo, M, Domingo, P et al.. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2017;35 (2):88-99. doi: 10.1016/j.eimc.2016.06.013. PubMed PMID:27459919 .
Search PubMed
  1. Pulido, F, Ribera, E, Lagarde, M, Pérez-Valero, I, Palacios, R, Iribarren, JA et al.. Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial. Clin Infect Dis. 2017;65 (12):2112-2118. doi: 10.1093/cid/cix734. PubMed PMID:29020293 .
Search PubMed
  1. Kestler, M, Muñoz, P, Marín, M, Goenaga, MA, Idígoras Viedma, P, de Alarcón, A et al.. Endocarditis caused by anaerobic bacteria. Anaerobe. 2017;47 :33-38. doi: 10.1016/j.anaerobe.2017.04.002. PubMed PMID:28389412 .
Search PubMed
  1. Crespo, M, Navarro, J, Moreno, S, Sanz, J, Márquez, M, Zamora, J et al.. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group. Enferm Infecc Microbiol Clin. 2017;35 (8):493-498. doi: 10.1016/j.eimc.2016.02.029. PubMed PMID:27061975 .
Search PubMed
  1. Arboledas, JCA, Guerrero, IP, Rodríguez, MJB, Martos, ET, Pérez, AB, León, CC et al.. Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals. Diagn Microbiol Infect Dis. 2017;89 (1):29-34. doi: 10.1016/j.diagmicrobio.2017.06.006. PubMed PMID:28669680 .
Search PubMed
  1. Rivero-Juarez, A, Lopez-Cortes, LF, Castaño, M, Merino, D, Marquez, M, Mancebo, M et al.. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy. Eur J Clin Microbiol Infect Dis. 2017;36 (3):487-494. doi: 10.1007/s10096-016-2822-6. PubMed PMID:27787664 PubMed Central PMC5309278.
Search PubMed
  1. Becerra-Muñoz, VM, Ruíz-Morales, J, Rodríguez-Bailón, I, Sánchez-Espín, G, López-Garrido, MA, Robledo-Carmona, J et al.. Infective endocarditis in patients with bicuspid aortic valve: Clinical characteristics, complications, and prognosis. Enferm Infecc Microbiol Clin. 2017;35 (10):645-650. doi: 10.1016/j.eimc.2016.06.017. PubMed PMID:27493083 .
Search PubMed
  1. Neukam, K, Morano-Amado, LE, Rivero-Juárez, A, Macías, J, Granados, R, Romero-Palacios, A et al.. Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients. Eur J Clin Microbiol Infect Dis. 2017;36 (5):853-861. doi: 10.1007/s10096-016-2871-x. PubMed PMID:28004322 .
Search PubMed
  1. Merchante, N, Rivero-Juárez, A, Téllez, F, Merino, D, Ríos-Villegas, MJ, Ojeda-Burgos, G et al.. Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis. AIDS. 2017;31 (4):493-500. doi: 10.1097/QAD.0000000000001358. PubMed PMID:27922855 .
Search PubMed
  1. Aguilera, A, Navarro, D, Rodríguez-Frias, F, Viciana, I, Martínez-Sapiña, AM, Rodríguez, MJ et al.. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study). J Viral Hepat. 2017;24 (9):725-732. doi: 10.1111/jvh.12700. PubMed PMID:28248445 .
Search PubMed
  1. Perez-Molina, JA, Rubio, R, Rivero, A, Pasquau, J, Suárez-Lozano, I, Riera, M et al.. Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study). J Antimicrob Chemother. 2017;72 (1):246-253. doi: 10.1093/jac/dkw379. PubMed PMID:27629070 .
Search PubMed
  1. Viciana, I, González-Domenech, CM, Palacios, R, Delgado, M, Del Arco, A, Tellez, F et al.. Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain. J Antimicrob Chemother. 2016;71 (2):357-61. doi: 10.1093/jac/dkv332. PubMed PMID:26483513 .
Search PubMed
  1. López-Cortés, LF, Castaño, MA, López-Ruz, MA, Rios-Villegas, MJ, Hernández-Quero, J, Merino, D et al.. Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens. PLoS One. 2016;11 (2):e0148924. doi: 10.1371/journal.pone.0148924. PubMed PMID:26872331 PubMed Central PMC4752289.
Search PubMed
  1. Palacios, R, Pérez-Hernández, IA, Martínez, MA, Mayorga, ML, González-Domenech, CM, Omar, M et al.. Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART. Eur J Clin Microbiol Infect Dis. 2016;35 (5):815-9. doi: 10.1007/s10096-016-2602-3. PubMed PMID:26879392 .
Search PubMed
  1. Experts Panel from the Secretary of the National AIDS Plan (SPNS), Spanish Society of Psychiatry (SEP), AIDS Study Group (GeSIDA), Spanish Society of Pediatric Infectious Diseases (SEIP). Electronic address: rpolor@msssi.es. Executive summary of the consensus document on psychiatric and psychological aspects in adults and children with HIV infection. Enferm Infecc Microbiol Clin. 2016;34 (1):54-60. doi: 10.1016/j.eimc.2015.07.017. PubMed PMID:26409724 .
Search PubMed
  1. AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases, Clinical Microbiology, the National AIDS Plan. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2016). Enferm Infecc Microbiol Clin. ;34 (7):439-51. doi: 10.1016/j.eimc.2016.02.028. PubMed PMID:27068257 .
Search PubMed
  1. Neukam, K, Espinosa, N, Collado, A, Delgado-Fernández, M, Jiménez-Aguilar, P, Rivero-Juárez, A et al.. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PLoS One. 2016;11 (5):e0155842. doi: 10.1371/journal.pone.0155842. PubMed PMID:27195797 PubMed Central PMC4873169.
Search PubMed
  1. Martínez-Sellés, M, Bouza, E, Díez-Villanueva, P, Valerio, M, Fariñas, MC, Muñoz-García, AJ et al.. Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation. EuroIntervention. 2016;11 (10):1180-7. doi: 10.4244/EIJY15M02_05. PubMed PMID:25671426 .
Search PubMed
  1. Díez-Villanueva, P, Muñoz, P, Marín, M, Bermejo, J, de Alarcón González, A, Fariñas, MC et al.. Infective endocarditis: Absence of microbiological diagnosis is an independent predictor of inhospital mortality. Int J Cardiol. 2016;220 :162-5. doi: 10.1016/j.ijcard.2016.06.129. PubMed PMID:27379918 .
Search PubMed
  1. Neukam, K, Mira, JA, Collado, A, Rivero-Juárez, A, Monje-Agudo, P, Ruiz-Morales, J et al.. Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort. PLoS One. 2016;11 (2):e0148104. doi: 10.1371/journal.pone.0148104. PubMed PMID:26848975 PubMed Central PMC4743911.
Search PubMed
  1. Teófilo, E, Rocha-Pereira, N, Kuhlmann, B, Antela, A, Knechten, H, Santos, J et al.. Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study. HIV Clin Trials. 2016;17 (1):17-28. doi: 10.1080/15284336.2015.1112494. PubMed PMID:26899539 PubMed Central PMC4975100.
Search PubMed
  1. Neukam, K, Viciana, P, Ojeda-Burgos, G, Delgado-Fernández, M, Ríos, MJ, Macías, J et al.. No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014. BMC Infect Dis. 2016;16 :489. doi: 10.1186/s12879-016-1826-2. PubMed PMID:27634297 PubMed Central PMC5025585.
Search PubMed
  1. Alejos, B, Hernando, V, Iribarren, J, Gonzalez-García, J, Hernando, A, Santos, J et al.. Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection. Medicine (Baltimore). 2016;95 (36):e4727. doi: 10.1097/MD.0000000000004727. PubMed PMID:27603368 PubMed Central PMC5023891.
Search PubMed
  1. Gallardo-García, MM, Sánchez-Espín, G, Ivanova-Georgieva, R, Ruíz-Morales, J, Rodríguez-Bailón, I, Viñuela González, V et al.. Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study. Eur J Clin Microbiol Infect Dis. 2016;35 (5):821-8. doi: 10.1007/s10096-016-2603-2. PubMed PMID:26951263 .
Search PubMed
  1. Riera, M, Esteban, H, Suarez, I, Palacios, R, Lozano, F, Blanco, JR et al.. [Validation and adhesion to GESIDA quality indicators in patients with HIV infection]. Enferm Infecc Microbiol Clin. ;34 (6):346-52. doi: 10.1016/j.eimc.2015.09.003. PubMed PMID:26530224 .
Search PubMed
  1. Neukam, K, Munteanu, DI, Rivero-Juárez, A, Lutz, T, Fehr, J, Mandorfer, M et al.. Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy. PLoS One. 2015;10 (4):e0125080. doi: 10.1371/journal.pone.0125080. PubMed PMID:25923540 PubMed Central PMC4414348.
Search PubMed
  1. Estrada, V, Bernardino, JI, Masiá, M, Iribarren, JA, Ortega, A, Lozano, F et al.. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain. HIV Clin Trials. ;16 (2):57-65. doi: 10.1179/1528433614Z.0000000008. PubMed PMID:25874992 .
Search PubMed
  1. Rivero-Juarez, A, Gutierrez-Valencia, A, Castaño, M, Merino, D, Neukam, K, Ríos-Villegas, MJ et al.. Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain. Eur J Clin Microbiol Infect Dis. 2015;34 (11):2247-55. doi: 10.1007/s10096-015-2476-9. PubMed PMID:26342330 PubMed Central PMC4607719.
Search PubMed
  1. Perez-Molina, JA, Rubio, R, Rivero, A, Pasquau, J, Suárez-Lozano, I, Riera, M et al.. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial. Lancet Infect Dis. 2015;15 (7):775-84. doi: 10.1016/S1473-3099(15)00097-3. PubMed PMID:26062881 .
Search PubMed
  1. Mira, JA, Neukam, K, López-Cortés, LF, Rivero-Juárez, A, Téllez, F, Girón-González, JA et al.. Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia. Eur J Clin Microbiol Infect Dis. 2015;34 (9):1879-84. doi: 10.1007/s10096-015-2426-6. PubMed PMID:26115631 .
Search PubMed
  1. Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids Plan (SPNS), Aids Study Group (GeSIDA), Polo Rodríguez, R, Galindo Puerto, MJ, Dueñas, C, Gómez Candela, C, Estrada, V et al.. Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. Enferm Infecc Microbiol Clin. 2015;33 (1):41-7. doi: 10.1016/j.eimc.2014.05.018. PubMed PMID:25096166 .
Search PubMed
  1. Expert Panel of GESIDA and the National AIDS Plan, Berenguer, J, Polo, R, Aldeguer, JL, Lozano, F, Aguirrebengoa, K et al.. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015). Enferm Infecc Microbiol Clin. 2015;33 (8):544-56. doi: 10.1016/j.eimc.2015.03.017. PubMed PMID:26021186 .
Search PubMed
  1. Neukam, K, Munteanu, D, Haubitz, S, Mira, JA, Ingiliz, P, Rivero-Juárez, A et al.. Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection. Antivir Ther. 2015;20 (4):407-13. doi: 10.3851/IMP2921. PubMed PMID:25470790 .
Search PubMed
  1. Ruiz-Morales, J, Ivanova-Georgieva, R, Fernández-Hidalgo, N, García-Cabrera, E, Miró, JM, Muñoz, P et al.. Left-sided infective endocarditis in patients with liver cirrhosis. J Infect. 2015;71 (6):627-41. doi: 10.1016/j.jinf.2015.09.005. PubMed PMID:26408206 .
Search PubMed
  1. Macías, J, López-Cortés, LF, Téllez, F, Recio, E, Ojeda-Burgos, G, Ríos, MJ et al.. Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. PLoS One. 2015;10 (12):e0143492. doi: 10.1371/journal.pone.0143492. PubMed PMID:26640956 PubMed Central PMC4671604.
Search PubMed
  1. Macías, J, Mancebo, M, Márquez, M, Merino, D, Téllez, F, Rivero, A et al.. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term. Hepatology. 2015;61 (5):1503-11. doi: 10.1002/hep.27674. PubMed PMID:25545020 .
Search PubMed
  1. Merchante, N, Téllez, F, Rivero-Juárez, A, Ríos-Villegas, MJ, Merino, D, Márquez-Solero, M et al.. Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis. BMC Infect Dis. 2015;15 :557. doi: 10.1186/s12879-015-1291-3. PubMed PMID:26643257 PubMed Central PMC4672550.
Search PubMed
  1. López-Calderón, C, Palacios, R, Cobo, A, Nuño, E, Ruiz, J, Márquez, M et al.. Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity. Int J STD AIDS. 2015;26 (6):393-7. doi: 10.1177/0956462414539669. PubMed PMID:24912540 .
Search PubMed
  1. González-Domenech, CM, Antequera Martín-Portugués, I, Clavijo-Frutos, E, Márquez-Solero, M, Santos-González, J, Palacios-Muñoz, R et al.. [Syphilis and human immunodeficiency virus infection: an endemic infection in men who have sex with men]. Enferm Infecc Microbiol Clin. 2015;33 (1):32-6. doi: 10.1016/j.eimc.2014.07.013. PubMed PMID:25444048 .
Search PubMed

Subscribe

Suscríbete a nuestro Newsletter y recibe en tu correo todas las últimas novedades del Instituto.
Consulta el histórico de Newsletter:

Calle Doctor Miguel Díaz Recio , 28 Málaga 29010

(+34) 951 440 260
Fax: (+34) 951 440 263